Volume 2, Issue 2 (April 2023)                   Health Science Monitor 2023, 2(2): 90-98 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kazempour Dizaji M, Varahram M, Tabarsi P, Roozbahani R, Zare A, Moniri A, et al . Prediction of multidrug-resistant tuberculosis in tuberculosis patients using perceptron artificial neural networks model. Health Science Monitor 2023; 2 (2) :90-98
URL: http://hsm.umsu.ac.ir/article-1-101-en.html
Mycobacteriology Research Center (MRC), National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract:   (468 Views)
Background & Aims: Diagnosis and treatment of patients with multidrug-resistant tuberculosis (MDR-TB) are very important. Hence, it is necessary to predict and diagnose these patients based on individual, demographic and clinical characteristics before starting treatment. This study aimed to predict MDR-TB in TB patients using the perceptron artificial neural networks (ANNs) model.
Materials & Methods: This retrospective cohort study was conducted on 1,050 TB patients who have been treated in Masih Daneshvari Hospital, Tehran, Iran from 2005 to 2015. Data on personal and demographic information, as well as medical data such as drug therapy, final outcome of treatment, and the diagnosis of MDR-TB, were collected from the patients' medical records.
Results: The results of this study indicated that the predictive power of MDR-TB for both training and testing groups was 85% and 80%, respectively. Also, the variables of marital status, education, drug use, being imprisoned, extrapulmonary TB, history of comorbidities, AIDS, patients' age, and family size were identified as very effective factors. However, variables of residence, smoking history, contact with a TB person, pulmonary TB, drug side effects, nationality, and diabetes were found as effective factors in predicting the development of MDR-TB.
Conclusion: Application of the perceptron ANNs model in the study of MDR-TB is able to create new horizons in the diagnosis of these patients due to high predictive accuracy.
Full-Text [PDF 428 kb]   (330 Downloads)    
Type of Study: Research | Subject: General
Received: 2022/12/15 | Accepted: 2023/01/2 | Published: 2023/04/21

References
1. Organization WH. Tuberculosis Fact sheet N°104 [Internet]. 2016 [cited 2023 Apr 15]. Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis [URL]
2. Organization WH. Global tuberculosis control: WHO report 2010 [Internet]. World Health Organization [URL]
3. 2010 [cited 2023 Apr 15]. Available from: https://apps.who.int/iris/handle/10665/44425 [URL]
4. Rom WN, Garay S, editors. Tuberculosis Boston. New York, Toronto, London: Little, Brown and Company; 1996. [URL]
5. Mansoori S, Aghazadeh M, Asmar M, Masjedi MR, Velayati AA. Comparative study of initial and acquired drug resistance in pulmonary tuberculosis. Revue internationale des services de santé des forces armées. 2003;76(1):45-9. [Google Scholar]
6. Mirsaeidi SM, Tabarsi P, Khoshnood K, Mansouri D, Masjedi MR, Velayati AA. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran. International journal of infectious diseases. 2005;9(6):317-22. [DOI] [PMID]
7. Organization WH. Anti-tuberculosis drug resistance in the world: third global report [Internet]. 2004 [cited 2023 Apr 15]. Available from: https://apps.who.int/iris/handle/10665/42910 [URL]
8. Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, Ziazarifi AH, et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest Journal. 2009;136(2):420-5. [DOI] [PMID]
9. Kay JW, Titterington DM, editors. Statistics and neural networks: advances at the interface. Oxford University Press on Demand; 1999. [Google Books]
10. Warner B, Misra M. Understanding neural networks as statistical tools. The American Statistician. 1996;50(4):284-93. https://doi.org/10.2307/2684922 [DOI]
11. Sevim T, Doganay M, Bakir M, Kilic A, Kayacan O, Kocagoz T, et al. Treatment outcome of relapse and defaulter pulmonary tuberculosis patients. The International Journal of Tuberculosis and Lung Disease. 2002;6(4):320-5. [Google Scholar]
12. Salaniponi FM-L, Nyirenda TEH, Kemp JRHJr., Squire SBHJr., Godfrey-Faussett PHJr., Harries ADHJr… Characteristics, management and outcome of patients with recurrent tuberculosis under routine programme conditions in Malawi. The International Journal of Tuberculosis and Lung Disease. 2003;7(10):948-52. [Google Scholar]
13. Quy HTTJr., Lan NTNJr., Borgdorff MWJr., Grosset JHJr., Linh PDJr., Tung LBHJr., et al… Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate? The International Journal of Tuberculosis and Lung Disease. 2003;7(7):631-6. [Google Scholar]
14. Mirsaeidi MS, Tabarsi P, Farnia P, Ebrahimi G, Morris MW, Masjedi MR, et al. Trends of drug resistant Mycobacterium tuberculosis in a tertiary tuberculosis center in Iran. Saudi medical journal. 2007;28(4):544-7. [Google Scholar]
15. Kritski AL, Marques MJ, Rabahi MF, Vieira MA, Werneck-Barroso E, Carvalho CE, et al. Retreatment tuberculosis cases: factors associated with drug resistance and adverse outcomes. CHEST Journal. 1997;111(5):1162-7. [DOI] [PMID]
16. Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ, et al. Patients with previously treated tuberculosis no longer neglected. Clinical infectious diseases. 2007;44(1):61-4. [DOI] [PMID]
17. Sargent DJ. Comparison of artificial neural networks with other statistical approaches: results from medical data sets. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2001;91(S8):1636-42. https://doi.org/10.1002/1097-0142(20010415)91:8+<1636::AID-CNCR1176>3.0.CO;2-D [DOI] [PMID]
18. Chi C-L, Street WN, Wolberg WH. Application of artificial neural network-based survival analysis on two breast cancer datasets. In: AMIA Annual Symposium Proceedings [Internet]. American Medical Informatics Association; 2007 [cited 2023 Apr 15]. p. 130-4. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2655849/ [PMID] [PMCID]
19. Ahmed FE. Artificial neural networks for diagnosis and survival prediction in colon cancer. Molecular cancer. 2005;4(1):29. [DOI] [PMID] [PMCID]
20. Akl A, Ismail AM, Ghoneim MA. Prediction of graft survival of living-donor kidney transplantation: nomograms or artificial neural networks? Transplantation. 2008;86(10):1401-6. [DOI] [PMID]
21. Tsai P-FJ, Lee T-CJ, Chen J-HJ, Yen D-CJ. Length of hospital stay prediction at the admission stage for cardiology patients using artificial neural network. Journal of healthcare engineering [Internet]. 2016 [cited 2023 Apr 15];2016:1-10. Available from: https://www.hindawi.com/journals/jhe/2016/7035463/ [DOI] [PMID] [PMCID]
22. LaFaro RJ, Stansbury LG, Scalea TM, Bartlett ST, Rabin J. Neural network prediction of ICU length of stay following cardiac surgery based on pre-incision variables. PLoS One. 2015;10(12):e0145395. [DOI] [PMID] [PMCID]
23. Yegnanarayana B. Artificial neural networks. New Delhi: PHI Learning; 2009. [Google Books]
24. Kazempour-Dizaji M, Ghafari A, Ghahramani S, Tabatabaei SM, Holakouie-Naieni K. Estimation of Ten-Year Survival of Patients with Pulmonary Tuberculosis Based on the Competing Risks Model in Iran. Tanaffos. 2016;15(1):37-43. [URL]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Health Science Monitor

Designed & Developed by : Yektaweb